Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Chapter 4729:8-2 | Drugs Required to be Reported to Ohio Automated Rx Reporting System (OARRS)

 
 
 
Rule
Rule 4729:8-2-01 | List of drugs to be reported.
 

Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription, personally furnished by a prescriber, or sold at wholesale to a terminal distributor of dangerous drugs shall be submitted to the state board of pharmacy pursuant to sections 4729.77, 4729.78 and 4729.79 of the Revised Code and this division of the Administrative Code:

(A) All schedule II controlled substances;

(B) All schedule III controlled substances;

(C) All schedule IV controlled substances;

(D) All schedule V controlled substances.

Supplemental Information

Authorized By: 3719.28, 4729.26, 4729.84
Amplifies: 4729.75, 4729.76, 4729.77, 4729.78, 4729.79, 4729.80, 4729.81, 4729.82, 4729.83, 4729.84
Five Year Review Date: 3/15/2024
Prior Effective Dates: 1/15/2016
Rule 4729:8-2-02 | Additional drugs to be reported.
 

(A) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription, personally furnished by a prescriber, or sold at wholesale to a prescriber or terminal distributor of dangerous drugs shall be submitted to the state board of pharmacy in accordance with sections 4729.77, 4729.78 and 4729.79 of the Revised Code and this division of the Administrative Code:

All dangerous drug products containing gabapentin.

(B) Pursuant to section 4729.75 of the Revised Code, the required information for the following drugs pursuant to an outpatient prescription shall be submitted to the state board of pharmacy in accordance with section 4729.77 of the Revised Code and this division of the Administrative Code:

All dangerous drug products containing naltrexone that are indicated for the treatment of alcohol dependence or the prevention of relapse to opioid dependence.

Supplemental Information

Authorized By: 4729.84, 4729.26, 3719.28
Amplifies: 4729.75, 4729.84, 4729.83, 4729.82, 4729.81, 4729.80, 4729.79, 4729.78, 4729.77, 4729.76
Five Year Review Date: 3/15/2024